RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kwangdong Pharmaceutical Co Stock

Kwangdong Pharmaceutical Co Stocks 2024

Kwangdong Pharmaceutical Co Stocks

40.47 M

Ticker

009290.KS

ISIN

KR7009290008

In 2024, Kwangdong Pharmaceutical Co had 40.47 M outstanding stocks, a -1.48% change from the 41.08 M stocks in the previous year.

The Kwangdong Pharmaceutical Co Stocks history

YEARNUMBER OF STOCKS (undefined KRW)
202340.47
202241.08
202141.13
202041
201940
201841
201741
201641
201540
201440
201341
201242
201144
201046
200947
200848
200749
200650
200550
200451

Kwangdong Pharmaceutical Co shares outstanding

The number of shares was Kwangdong Pharmaceutical Co in 2023 — This indicates how many shares 40.471 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kwangdong Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kwangdong Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kwangdong Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kwangdong Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kwangdong Pharmaceutical Co Aktienanalyse

What does Kwangdong Pharmaceutical Co do?

Kwangdong Pharmaceutical Co Ltd was founded in 1936 in South Korea and has since grown to become one of the leading manufacturers of pharmaceutical and cosmetic products. The company is headquartered in Seoul and employs over 4,000 employees. The business model of Kwangdong Pharmaceutical is based on a wide range of products that are distributed both domestically and internationally. The company aims to develop products that help people lead a healthier and happier life. One of the company's most important business areas is the manufacture of various types of medicines. Kwangdong specializes in developing products for the treatment of chronic diseases such as diabetes, hypertension, and arthritis. In addition, the company also offers medications for gastrointestinal, respiratory, and nervous system disorders. Another important business area of Kwangdong is the production of cosmetic products. The focus here is on the production of skincare products such as creams, lotions, and serums, as well as makeup products such as lipsticks, eyeshadows, and nail polishes. The company places great emphasis on the use of natural ingredients and the development of products that are both effective and skin-friendly. In addition to pharmaceuticals and cosmetic products, Kwangdong also manufactures dietary supplements. These products are offered for supporting the immune system, improving digestion, and regulating blood sugar levels, among other benefits. Throughout its history, Kwangdong has developed and launched a number of innovative products. One example is the product "Keo-Pok-Chong," a herbal medicine for relieving cough and cold symptoms. Another example is the "Oriental Beauty Tea Set," which consists of various tea varieties based on traditional Korean healing methods and is said to have a positive impact on health. Overall, Kwangdong Pharmaceutical Co Ltd is a company characterized by a wide range of products and a strong focus on health and well-being. The company has produced a variety of successful products in its history and continuously works on the development of new products that meet the needs of its customers. Kwangdong Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Kwangdong Pharmaceutical Co's Shares Outstanding

Kwangdong Pharmaceutical Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Kwangdong Pharmaceutical Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Kwangdong Pharmaceutical Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Kwangdong Pharmaceutical Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Kwangdong Pharmaceutical Co stock

How many stocks are there of Kwangdong Pharmaceutical Co?

The current number of stocks of Kwangdong Pharmaceutical Co is 40.47 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Kwangdong Pharmaceutical Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Kwangdong Pharmaceutical Co evolved in recent years?

The number of shares of Kwangdong Pharmaceutical Co has increased by -1.48% gesunken compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Kwangdong Pharmaceutical Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Kwangdong Pharmaceutical Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Kwangdong Pharmaceutical Co pay?

Over the past 12 months, Kwangdong Pharmaceutical Co paid a dividend of 100 KRW . This corresponds to a dividend yield of about 1.8 %. For the coming 12 months, Kwangdong Pharmaceutical Co is expected to pay a dividend of 100 KRW.

What is the dividend yield of Kwangdong Pharmaceutical Co?

The current dividend yield of Kwangdong Pharmaceutical Co is 1.8 %.

When does Kwangdong Pharmaceutical Co pay dividends?

Kwangdong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Kwangdong Pharmaceutical Co?

Kwangdong Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Kwangdong Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 100 KRW are expected. This corresponds to a dividend yield of 1.8 %.

In which sector is Kwangdong Pharmaceutical Co located?

Kwangdong Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kwangdong Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kwangdong Pharmaceutical Co from 4/23/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Kwangdong Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 4/23/2024.

What was the dividend of Kwangdong Pharmaceutical Co in the year 2023?

In the year 2023, Kwangdong Pharmaceutical Co distributed 100 KRW as dividends.

In which currency does Kwangdong Pharmaceutical Co pay out the dividend?

The dividends of Kwangdong Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kwangdong Pharmaceutical Co

Our stock analysis for Kwangdong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kwangdong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.